AnalysisNews

PAHC today

$35.13-$0.02 (-0.06%)close Nov 12, 2026

Trend

DailyUptrend (confirmed)

4 hourLeaning Bullish

1 hourBullish

15 minLeaning Bearish

5 minBullish

Daily trend turns down below $32.88

Key levels

Resistance$37.83

Resistance$36.03

Support$32.91

Support$30.64

Latest news & SEC filings

EarningsPhibro Animal Health holds Q1 2027 earnings call

EarningsPhibro Animal Health posts first quarter fiscal 2027 results

GuidancePhibro Animal Health keeps FY2027 EPS and sales guidance unchanged

SEC FilingPhibro Animal Health Corp filed a report on a major company event (Form 8-K)

All PAHC news →

About Phibro Animal Health

Phibro Animal Health creates and sells treatments and nutritional aids for farm livestock including poultry, cattle, swine, and fish, as well as some pet products. Its lineup covers germ-fighting medicines, parasite controls, specialty feed additives, vaccines, and adjuvants, plus mineral blends that supplement animal diets. The company also makes ingredients used in beauty products, manufacturing processes, and catalysts. Buyers include farmers, feed makers, distributors, and veterinarians, and it sells worldwide.

Based on the company's 10-K filed Aug 26, 2026.

Nasdaq · Healthcare

PHIBRO ANIMAL HEALTH CORP (PAHC)

$35.13-0.02 (-0.06%)
WATCHLISTGrade: B+Risk: LOW
1D5D1M1Y5YMaxSign up for all timeframes
34.3335.7037.0738.4435.13Oct 12Oct 20Oct 28Nov 5
High35.51
Low34.79
Open35.19
Volume22K
Avg Vol187K
VWAP35.17
30d High39.81
30d Low32.96
30d Chg-5.67%

What Is the Price Target for PAHC?

SEPT Low Target

$37.40

SEPT Mid Target

$44.00

SEPT High Target

$50.60

Analyst Consensus

$44.00

Current: $32.96Upside: +33.5%Confidence: 40%Method: Analyst Consensus

Is PAHC a Buy or Sell Right Now?

72
Investability Score
WATCHLIST12-18 months

Thesis

  • •Revenue growing 17.1% YoY with ACCELERATING trend — accelerating momentum.

AI-Powered Trading Signals

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for PAHC.

Start Free Trial →

Is PAHC Overvalued or Undervalued?

Valuation Verdict

UNDERVALUED

Methods Used

P/E Forward, P/B, PEG, Analyst Consensus

Fair Value

$56.05

50

Moat Score

NARROW

7/9

Piotroski Score

3.1

Altman Z-Score

What Is Smart Money Doing with PAHC?

Insider Signal

SELLING

1 buys / 18 sells (90d)

Congress Signal

NEUTRAL

0 buys / 0 sells (90d)

Institutional

ACCUMULATING

Short Squeeze Risk

LOW

Signal: NEUTRAL

Recent Insider Activity

NameTitleTypeSharesValueDate
CORCORAN E THOMASdirectorBuy10,000$318KMay 29, 2026

Track Smart Money Across 4,000+ Stocks

Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.

See All Smart Money Signals →

PAHC Growth Story

Revenue YoY

17.1%

3yr Revenue CAGR

15.8%

EPS Growth YoY

104.2%

FCF Growth YoY

-76.4%

Revenue Trend

ACCELERATING

Dark Pool Trades for PAHC

PREVIEW

SEPT Investing tracks real-time dark pool institutional trades for PAHC, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.

TimePriceSizeValueSide
14:53:40$34.792,850$$99KSELL
18:58:09$35.012,000$$70KSELL
15:04:57$34.951,014$$35KBUY
20:58:13$34.734,000$$139KBUY
20:20:36$34.981,000$$35KBUY

5 dark pool trades shown · $$378K preview volume

Real-time institutional flow, block trades, and net positioning

See all dark pool activity

Full AI Research Report

SEPT's Trading AI has generated a free, downloadable PDF research report for PHIBRO ANIMAL HEALTH CORP (PAHC) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.

Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...

AI-Powered Trading Signals.

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.

Try SEPT Free for 7 Days →

PAHC — frequently asked questions

What is PAHC stock price today?

PHIBRO ANIMAL HEALTH CORP (PAHC) is at $35.13, down 0.06% (-$0.02) at the Nov 12, 2026 close.

Why is PAHC stock moving today?

Latest PAHC news — Nov 5, 2026: Phibro Animal Health holds Q1 2027 earnings call · Nov 4, 2026: Phibro Animal Health posts first quarter fiscal 2027 results

What is the PAHC price target?

The average analyst price target for PAHC is $44.00, ranging from $44 to $44, based on 1 analysts. Latest: Citigroup maintains on May 14, 2026.

What do analysts rate PAHC?

Analyst ratings for PAHC: 0 Buy, 2 Hold, 0 Sell — consensus Hold.

Did PAHC beat earnings?

PAHC last reported on Aug 26, 2026: EPS $0.85 vs $0.71 expected — a beat of 19.2%.

What is PAHC's P/E ratio?

PAHC trades at a P/E of 15.1.

Does PAHC pay a dividend?

Yes. PAHC's dividend yield is 1.88%.

What are PAHC support and resistance levels?

Support: $32.91, $30.64, $28.25. Resistance: $36.03, $37.83, $40.54.

What are insiders doing with PAHC?

Insider activity: SELLING, 1 buys and 18 sells in the last 90 days.

What is the latest news on PAHC?

Nov 5, 2026: Phibro Animal Health holds Q1 2027 earnings call · Nov 4, 2026: Phibro Animal Health posts first quarter fiscal 2027 results · Nov 4, 2026: Phibro Animal Health keeps FY2027 EPS and sales guidance unchanged